Pratika Prathamesh Mhambray

Sandu Pharmaceuticals Limited schedules board meeting on May 5, 2026 to recommend dividend for FY26. The intimation is made under SEBI LODR Regulation 29(1)(e) requirements for corporate disclosures.

Sandu Pharmaceuticals board meeting scheduled for May 5, 2026 to approve FY26 audited financial results. Board to consider recommending final dividend for financial year ended March 31, 2026. Trading